|
U.S. Supreme Court Prometheus Ruling May Limit Future Research
Last week’s U.S. Supreme Court decision on the patent eligibility of a diagnostic could have ramifications for in vitro diagnostic (IVD) devicemakers, limiting investment in novel tests because of uncertainty about what is and is not patentable, a U.S. patent attorney tells D&DL.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives